RedHill Biopharma Ltd. (RDHL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.25M |
| Enterprise Value | 352,950 |
| P/E Ratio | -0.38 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.58 |
| Price/Book Ratio | -0.63 |
| Enterprise/Revenue | -1.42 |
| Enterprise/EBITDA | 0.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -4.01 |
| Operating Margin | -3.1 |
| Return On Assets | -0.31 |
| Return On Equity | -4.38 |
| Revenue | 286,000 |
| Revenue/Share | 1.13 |
| Gross Profit | 286,000 |
| EBITDA | -7.65M |
| Net Income | -429,000 |
| Diluted EPS | 0 |
| Total Cash | 5.16M |
| Total Cash/Share | 2.86 |
| Total Debt | 1.08M |
| Total Debt/Equity | -1 |
| Current Ratio | 0.34 |
| Book Value Per Share | -0.6 |
| 52-Week Change | -64.95 |
| 52-Week High | 1.6 |
| 52-Week Low | 0.36 |
| Moving Average 50 Days | 0.5 |
| Moving Average 200 Days | 0.77 |
| Average Volume | 2.08M |
| Shares Outstanding | 3.14M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 20, 2024 |